The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. [electronic resource]
Producer: 20060929Description: 98-108 p. digitalISSN:- 0340-5354
- Alemtuzumab
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- administration & dosage
- Antirheumatic Agents -- administration & dosage
- Autoimmunity -- drug effects
- Child
- Child, Preschool
- Cohort Studies
- Disability Evaluation
- Drug Administration Schedule
- Female
- Humans
- Infant
- Magnetic Resonance Imaging -- methods
- Male
- Multiple Sclerosis -- therapy
- Retrospective Studies
- Secondary Prevention
- Time Factors
No physical items for this record
Publication Type: Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.